Extra Super Levitra is a clinically formulated, prescription-only medication designed to address two of the most prevalent male sexual health concerns simultaneously: erectile dysfunction (ED) and premature ejaculation (PE). Combining the proven efficacy of Vardenafil, a potent PDE5 inhibitor, with Dapoxetine, a selective serotonin reuptake inhibitor (SSRI) specifically developed for PE, this dual-component therapy offers a comprehensive pharmacological approach. It works by enhancing blood flow to the penile tissues to facilitate firm, sustainable erections, while concurrently modulating serotonin levels in the central nervous system to significantly delay ejaculation and improve control. Intended for adult men diagnosed with both conditions, it represents a significant advancement in sexual medicine, providing a streamlined, evidence-based treatment option that targets the physiological and neurological aspects of sexual performance.

Features

• Active ingredients: Vardenafil 20mg and Dapoxetine 60mg per tablet
• Pharmaceutical class: PDE5 inhibitor (Vardenafil) and short-acting SSRI (Dapoxetine)
• Onset of action: Typically within 25-60 minutes post-administration
• Duration of effect: Vardenafil effects last up to 5-6 hours; Dapoxetine effects are acute and event-based
• Administration: Oral tablet, taken with or without food (though high-fat meals may delay absorption)
• Manufacturer: Produced under strict GMP (Good Manufacturing Practice) standards

Benefits

• Achieves and maintains firm erections sufficient for satisfactory sexual activity
• Significantly increases intravaginal ejaculatory latency time (IELT), enhancing sexual endurance
• Improves overall sexual confidence and reduces performance-related anxiety
• Provides a dual therapeutic effect from a single tablet, simplifying treatment regimen
• Allows for spontaneity in sexual activity due to rapid onset and predictable duration
• Supported by clinical studies demonstrating efficacy in comorbid ED and PE populations

Common use

Extra Super Levitra is prescribed for the treatment of erectile dysfunction concurrent with premature ejaculation in sexually active adult males. It is not intended for use by women, adolescents, or men without a formal diagnosis of both conditions. The medication is used on an as-needed basis, approximately 1-2 hours prior to anticipated sexual activity. It is crucial to understand that sexual stimulation is required for the erectile response to occur; the drug facilitates the physiological process but does not induce an erection spontaneously. Patients are advised to use the medication no more than once in a 24-hour period.

Dosage and direction

The standard dosage is one tablet (containing Vardenafil 20mg and Dapoxetine 60mg) taken orally with a full glass of water. It should be ingested approximately 1 hour before sexual activity, though the effective window ranges from 25 minutes to 2 hours post-consumption. Do not crush, chew, or break the tablet. Dosage adjustments may be necessary based on individual tolerance, efficacy, hepatic function, or concomitant medications—always follow the prescribing physician’s instructions precisely. Do not exceed one dose per day.

Precautions

Prior to initiation, a thorough medical evaluation is mandatory to assess cardiovascular health, as sexual activity carries potential cardiac risk. Use with caution in patients with anatomical penile deformities, bleeding disorders, or active peptic ulceration. Avoid excessive alcohol consumption, as it may increase the risk of orthostatic hypotension and diminish efficacy. This medication offers no protection against sexually transmitted infections. Regular follow-ups with a healthcare provider are recommended to monitor treatment response and potential adverse effects.

Contraindications

Extra Super Levitra is contraindicated in patients with:

• Hypersensitivity to Vardenafil, Dapoxetine, or any excipients in the formulation
• Concurrent administration of nitrates (e.g., nitroglycerin, isosorbide mononitrate) or nitric oxide donors
• Significant hepatic impairment (Child-Pugh class C)
• History of severe cardiovascular disorders (e.g., unstable angina, recent myocardial infarction, life-threatening arrhythmias)
• Hereditary problems of galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption
• Concurrent use with potent CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) or monoamine oxidase inhibitors (MAOIs)

Possible side effects

Common side effects (may affect up to 1 in 10 users):

• Headache, dizziness
• Flushing, nasal congestion
• Dyspepsia, nausea
• Insomnia, fatigue

Less common side effects (may affect up to 1 in 100 users):

• Visual disturbances (e.g., blurred vision, cyanopsia)
• Tinnitus, palpitations
• Orthostatic hypotension
• Diarrhea or constipation

Rare but serious side effects (seek immediate medical attention if experienced):

• Priapism (prolonged, painful erection lasting more than 4 hours)
• Sudden hearing loss or vision loss
• Severe cardiovascular events (e.g., angina, arrhythmia)
• Syncope or seizures
• Serotonin syndrome (agitation, hallucinations, tachycardia, hyperthermia)

Drug interaction

Extra Super Levitra has significant interaction potential:

• Nitrates: Concomitant use can cause profound hypotension; absolute contraindication.
• Alpha-blockers: May potentiate hypotensive effects; avoid concurrent use.
• CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): Increase Vardenafil exposure; contraindicated or dose reduction required.
• Other PDE5 inhibitors: Do not combine with similar agents.
• SSRIs, SNRIs, tricyclic antidepressants: Increased risk of serotonin syndrome with Dapoxetine.
• Antifungals, HIV protease inhibitors: May significantly elevate plasma concentrations.
• Moderate CYP3A4 inducers (e.g., rifampicin): May reduce efficacy.

Missed dose

As Extra Super Levitra is taken on an as-needed basis, there is no daily dosing schedule; hence, the concept of a “missed dose” does not apply. Do not take an additional tablet to make up for a missed pre-coital dose. Simply take one tablet approximately 1 hour before your next anticipated sexual activity, ensuring at least 24 hours have passed since the last administration.

Overdose

In case of suspected overdose (symptoms may include severe headache, profound hypotension, syncope, prolonged erection, or serotonin syndrome), seek immediate medical attention or contact a poison control center. Supportive measures should be instituted, including cardiovascular monitoring and symptomatic treatment. Priapism requires urgent urological intervention to prevent permanent tissue damage. Hemodialysis is not expected to significantly eliminate Vardenafil or Dapoxetine due to high protein binding.

Storage

Store below 25°C (77°F), in the original blister packaging, protected from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Do not dispose of medication via wastewater or household trash; consult your pharmacist or local waste disposal company for proper disposal methods.

Disclaimer

This information is for educational purposes only and does not constitute medical advice. Extra Super Levitra is a prescription medication and should only be used under the supervision of a qualified healthcare professional. Always consult your physician for a proper diagnosis and personalized treatment plan. Do not initiate, discontinue, or alter your dosage without medical guidance. The manufacturer and distributor are not liable for any misuse, adverse outcomes, or incorrect interpretation of this data.

Reviews

Clinical studies and patient reports indicate high satisfaction rates among men with comorbid ED and PE. In a 12-week, double-blind trial, approximately 85% of participants reported improved erectile function and significantly delayed ejaculation compared to placebo. Common patient feedback highlights the convenience of a combined tablet and the restoration of sexual confidence. However, individual experiences may vary, and some users report side effects such as mild headache or nausea, which often diminish with continued use. Long-term efficacy and safety data continue to be collected in post-marketing surveillance studies.